| |
| | NEJM -- The RET Proto-Oncogene in Multiple Endocrine Neoplasia Type 2 and Hirschsprung's Disease |
 | | Eng, C., Brody, L. C, Wagner, T. M U, Devilee, P., Vijg, J., Szabo, C., Tavtigian, S. V, Nathanson, K. L, Ostrander, E., Frank, T. Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1. |
 | | Eng, C., Thomas, G. A., Neuberg, D. S., Mulligan, L. M., Healey, C. S., Houghton, C., Frilling, A., Raue, F., Williams, E. D., Ponder, B. Mutation of the RET Proto-Oncogene Is Correlated with RET Immunostaining in Subpopulations of Cells in Sporadic Medullary Thyroid Carcinoma. |
 | | Sanicola, M., Hession, C., Worley, D., Carmillo, P., Ehrenfels, C., Walus, L., Robinson, S., Jaworski, G., Wei, H., Tizard, R., Whitty, A., Pepinsky, R. B., Cate, R. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. |
| content.nejm.org /cgi/content/short/335/13/943 (1207 words) |
|